首页> 美国卫生研究院文献>Biochemistry and Biophysics Reports >Analysis of mitochondrial DNA copy number variation in blood and tissue samples of metastatic breast cancer patients (A pilot study)
【2h】

Analysis of mitochondrial DNA copy number variation in blood and tissue samples of metastatic breast cancer patients (A pilot study)

机译:转移性乳腺癌患者血液和组织样本中的线粒体DNA拷贝数变化分析(试验研究)

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Changes in mitochondrial DNA (mt-DNA) copy number in blood/tissue have been linked to increased risk of several cancers; however, studies on their association in breast cancer is still lacking. In this pilot study, we investigated mt-DNA copy number variation in peripheral blood and tissue samples from metastatic breast cancer patients and compared their differences. For the study, peripheral blood samples from non-cancer individuals (control) and breast cancer patients, along with resected tissues from adjacent and tumor sites from same breast cancer patients were collected. Total genomic DNA was isolated and changes in mt-DNA copy number were measured by relative quantification using SYBR green based quantitative real time PCR method. Our results indicated a significant reduction in mt-DNA copy number in blood samples of breast cancer patients compared to control. However, a significantly higher mt-DNA copy number was observed in tumor tissue when compared with paired non tumor tissue. There was no significant difference in mt-DNA copy number between blood and adjacent tumor tissue samples of the breast cancer patients. Overall, our study reports for the first time a comparison of mt-DNA copy number in blood and paired tissue together and suggested that mt-DNA copy number is differentially regulated in blood and tumor tissues in breast cancer.
机译:血液/组织中的线粒体DNA(MT-DNA)拷贝数的变化与几种癌症的风险增加有关;然而,仍然缺乏对其在乳腺癌中的关联的研究。在该试点研究中,我们研究了从转移性乳腺癌患者的外周血和组织样本中的MT-DNA拷贝数变异,并比较了它们的差异。对于研究,来自非癌症个体(对照)和乳腺癌患者的外周血样品,以及来自来自相同乳腺癌患者的相邻和肿瘤部位的切除组织。分离总基因组DNA,通过使用SYBR绿基的定量实时PCR方法相对定量测量MT-DNA拷贝数的变化。我们的结果表明,与对照相比,乳腺癌患者血液样本中的MT-DNA拷贝数显着降低。然而,与配对的非肿瘤组织相比,在肿瘤组织中观察到显着较高的MT-DNA拷贝数。乳腺癌患者的血液和邻近肿瘤组织样品之间的MT-DNA拷贝数没有显着差异。总体而言,我们的研究报告首次将MT-DNA拷贝数在血液中的MT-DNA拷贝数在一起进行比较,并提出MT-DNA拷贝数在乳腺癌中的血液和肿瘤组织中差异调节。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号